How do the current and latest techniques stack up?
To view the prognosis click
here. (pdf format)
MAMMOGRAMS
the current gold standard for breast cancer screening MAGNETIC RESONANCE
IMAGING (MRI) sometimes used as an adjunct to mammography SELF-BREAST EXAMINATION
(SBE) puts patient screening in their own hands, literally NUCLEAR SCREENING
(SCINTIMAMMOGRAPHY AND POSITIVE EMISSION TOMOGRAPHY SCANNING) can be helpful
when combined with other techniques Mammography is backed by a large body
of scientific evidence. There are no absolute contraindications against
this method. Studies show low cost:benefit ratios. MRI appears to
be more sensitive than mammography for detecting cancerous lesions, especially
when theyre small. It can be argued that its better than mammography
for distinguishing between cancerous and non-cancerous lesions. Its
less painful than mammography. MRI is especially useful in patients at high risk
(ie, those with a strong familial history). In fact, evidence suggests that MRI
may be more cost-effective than mammography in high-risk women. The primary
advantage of SBE is that it allows for monthly evaluations at no financial cost.
SBE programs increase patient awareness of breast cancer screening and
risks. The combination of SBE and mammography has been shown to decrease
mortality rates. SBE is convenient and painless. Nuclear screening
tests (NSTs) are relatively sensitive. They detect changes in regional
blood flow and are potentially useful adjuncts to conventional methods that only
detect anatomic changes. This type of screen may identify local and distant
malignant spread, which could reduce the number of unnecessary mastectomies.
NSTs may be particularly useful for screening high-risk individuals. Sensitivity
is low compared to other imaging modalities. Specificity is generally low,
but this is true of virtually all current screening measures. Diagnostic
accuracy is compromised in individuals with dense, glandular breasts. The
procedure is more painful than other tests. Specificity for breast cancers
is relatively low, which may result in unnecessary biopsies. There are
several absolute contraindications for MRI, including pacemakers and surgical
clips. Claustrophobia prohibits many patients from submitting to MRI.
Theres relatively little research evidence supporting its use as a screening
tool. Self-exam is the least sensitive and specific screen. Its
of questionable benefit when not combined with mammography. On its own, it doesnt
reduce breast cancer mortality. SBE is highly non-specific in patients
with dense, glandular breasts. NSTs are relatively non-specific.
The procedures are necessarily invasive they require intravenous injections
of radioactive tracer materials. Theres less evidence supporting
the use of NSTs for breast cancer screening than any of the previously listed
methods. Mammograms are readily available across Canada and are performed
in virtually all radiology departments. Many communities and hospitals
dont have this technology. Waiting lists can be up to a year or more
for elective MRI. Access is virtually universal since patients perform
SBE on themselves. Anyone who can unhook a bra can perform SBE.
Access to NSTs is more limited than SBE or mammography. Only larger hospitals
have nuclear medicine departments. Waiting lists vary from weeks to months.
In Ontario, the technical cost is $37.70 for bilateral breast mammography.
The professional cost for reading mammograms is $21.50 per patient.
Costs are relatively high. In Ontario, the professional cost for reading MRI of
the thorax is $74.05 with $37.05 added for additional views. The only cost
is in patient time and effort. Direct costs of NSTs are greater than SBE
or mammography. In Ontario, the professional cost for an NST reading is
$43.90. The Ministry of Health Schedule of Benefits does not list technical
costs for either of these procedures but they should fall between $150 to $2000,
depending on a variety of factors, including size of area being visualized, size
of patient, etc.
|